- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Ovarian Carcinoma
Total 28286 results
-
City of Hope Medical CenterNational Cancer Institute (NCI)Not yet recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
Floor Backes, MDActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
Xiaohua Wu MDNot yet recruitingRelapsed Ovarian Cancer
-
Shanghai Gynecologic Oncology GroupZhejiang Cancer Hospital; Sun Yat-sen University; Fudan University; Shanghai Zhongshan...Active, not recruitingFallopian Tube Carcinoma | Ovarian Epithelial Cancer Recurrent | Primary Peritoneal CarcinomaChina
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Ovarian Carcinoma | Ovarian Clear Cell AdenocarcinomaUnited States, Korea, Republic of
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Acrivon TherapeuticsGOG FoundationRecruitingPlatinum-resistant Ovarian Cancer | Urothelial Carcinoma | Endometrial AdenocarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Resistant Ovarian CarcinomaUnited States
-
Novartis PharmaceuticalsTerminatedRenal Cell Carcinoma | Epithelial Ovarian CancerJapan, Australia, Belgium, Spain, United States, Switzerland
-
Shantou University Medical CollegeGuangdong ProCapZoom Biosciences Co., Ltd.Not yet recruitingOvarian Epithelial Carcinoma
-
Janssen Pharmaceutical K.K.Completed
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Medical Research Council; Southwest Oncology...CompletedPrimary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
Centre Leon BerardCancer Côte d'or registry; Cancer Calvados registryUnknownOvarian Epithelial CancerFrance
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Ovarian Endometrioid Adenocarcinoma | Ovarian Undifferentiated Carcinoma | Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Malignant Peritoneal Neoplasm | Endometrial Clear Cell Adenocarcinoma | Endometrial Endometrioid Adenocarcinoma | Endometrial Mixed Cell... and other conditionsUnited States
-
Jules Bordet InstituteCompletedFallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal CarcinomaBelgium
-
Roswell Park Cancer InstituteCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Tumor | Fallopian Tube Endometrioid Tumor | Ovarian Endometrioid Tumor | Fallopian Tube Mucinous Neoplasm | Fallopian Tube Serous Neoplasm | Ovarian Serous Tumor | Ovarian Mucinous...United States
-
Nuvectis Pharma, Inc.GOG Foundation; European Network of Gynaecological Oncological Trial Groups...RecruitingOvarian Cancer | Ovarian Endometrioid Adenocarcinoma | Advanced Solid Tumor | Ovarian Clear Cell Carcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Clear Cell Tumor | Ovarian Endometrioid Tumor | ARID1A Gene MutationUnited States, United Kingdom
-
Peking University People's HospitalBeijing Weixiao Biotechnology Development LimitedRecruitingRecurrent Ovarian Carcinoma | Platinum-resistant Ovarian CancerChina
-
National Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Brenner Tumor | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous Cystadenocarcinoma | Ovarian Mixed Epithelial Carcinoma | Ovarian Undifferentiated...United States
-
University of WashingtonNational Cancer Institute (NCI)CompletedFallopian Tube Cancer | Peritoneal Cavity Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous Cystadenocarcinoma and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedOvarian CarcinomaUnited States, Israel
-
CHU de Quebec-Universite LavalThe Cancer Research SocietyCompleted
-
All India Institute of Medical Sciences, New DelhiUnknown
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Celldex TherapeuticsRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial Serous Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Platinum-Sensitive Ovarian Carcinoma | Recurrent Fallopian... and other conditionsUnited States
-
University of Wisconsin, MadisonAventis PharmaceuticalsCompletedOvarian Carcinoma | Primary Peritoneal CarcinomaUnited States
-
University of Alabama at BirminghamBoehringer IngelheimCompletedRenal Cell Carcinoma | Non-squamous Non-small Cell Lung Cancer | Cervical Carcinoma | Colorectal Adenocarcinoma | Platinum-refractory Ovarian CarcinomaUnited States
-
National Cancer Institute, NaplesRecruitingLow-grade Serous Ovarian Carcinoma | Recurrent Invasive Borderline Serous Ovarian CancerItaly
-
Seoul National University HospitalUnknownFallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Epithelial Ovarian CarcinomaKorea, Republic of
-
Institut de Cancérologie de LorraineCompleted
-
Rennes University HospitalCompletedOvarian CarcinomaFrance
-
University Hospital, Basel, SwitzerlandWithdrawnEndometriosis | Endometrioid Carcinoma | Clear Cell Carcinoma
-
Sutro Biopharma, Inc.RecruitingOvarian Cancer | Fallopian Tube Cancer | Ovarian Carcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedSymptomatic Refractory Resistant Carcinoid DiseaseUnited Kingdom, Belgium, Italy, Singapore, Austria, France, Israel, Sweden, Germany, Spain, Canada, Argentina, Poland, United States, Brazil, Norway
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)CompletedPeritoneal Neoplasms | Recurrent Ovarian Carcinoma | Recurrent Uterine Corpus Carcinoma | Cervical Carcinoma | Ovarian Carcinoma | Recurrent Cervical Carcinoma | Uterine Corpus Cancer | Vulvar Carcinoma | Primary Peritoneal Carcinoma | Recurrent Vulvar CarcinomaUnited States
-
Lei LiRecruitingEpithelial Ovarian Cancer | Microsatellite Instability | PD-L1 | Nucleotide Variant | Copy Number Variation | Insertion-deletion Variation | Genomic Structural Variation | Total Mutation Burden | PD-1China
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Not yet recruitingFallopian Tube Carcinoma | Ovarian Carcinoma | Hereditary Breast and Ovarian Cancer Syndrome | Primary Peritoneal CarcinomaUnited States
-
GlaxoSmithKlineCompletedNeoplasms, OvarianUnited States
-
Life Research Technologies GmbHUnknownOvarian Epithelial CancerAustria, Hungary
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Ovarian Epithelial CancerUnited States
-
Mercy Medical CenterActive, not recruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Fallopian Tube Carcinoma | Ovarian Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingOvarian Carcinoma | High-grade Serous Ovarian CarcinomaKorea, Republic of, Spain, Poland, United States, Belgium, Canada, Chile, Israel, Italy, Singapore, Taiwan
-
The First People's Hospital of ChangzhouActive, not recruiting
-
University of WashingtonNational Cancer Institute (NCI)CompletedFallopian Tube Cancer | Peritoneal Cavity Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Brenner Tumor | Recurrent Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian Mucinous... and other conditionsUnited States
-
Sutro Biopharma, Inc.RecruitingOvarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Ovarian Carcinoma | Endometrioid Adenocarcinoma | Ovary Cancer | Primary Peritoneal CarcinomaUnited States, Spain
-
University of WashingtonNational Cancer Institute (NCI)CompletedCaregiver | Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian CancerUnited States
-
Jonsson Comprehensive Cancer CenterTetraLogic Pharmaceuticals; California Institute for Regenerative Medicine... and other collaboratorsWithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | High Grade Ovarian Serous Adenocarcinoma | High Grade Fallopian Tube Serous AdenocarcinomaUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Stage IV Ovarian Cancer | Stage III Ovarian Cancer | Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor | Stage IV Borderline Ovarian...Canada
-
ARCAGY/ GINECO GROUPMerck Sharp & Dohme LLCRecruitingAddition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT (PembroSCCOHT)Small Cell Ovarian CarcinomaFrance
-
NYU Langone HealthCompletedMicrovascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian CarcinomaOvarian NeoplasmsUnited States
-
Lei LiRecruitingChemotherapy | Ovarian Carcinoma | Survival Outcomes | Adverse Events | Niraparib | Anlotinib | CA125 | Targeted Therapy | Recurrent Ovarian CancerChina